Atlas Trials

Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Clinical trial NCT02560441 · UNKNOWN

Trial details

NCT number
NCT02560441
Sponsor
Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Start date
2015-09-01
Primary completion
2022-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.